Image via Wikipedia Healthcare Sector Breaking News for Tuesday, September 07, 2010Bristol-Myers Squib to merge with ZymoGenetics
After the bell Tuesday, Bristol-Myers Squibb Company (NYSE:BMY) and ZymoGenetics, Inc. (NASDAQ: ZGEN) announced today that the companies have signed a definitive agreement providing for the acquisition of ZymoGenetics by Bristol-Myers Squibb, for $9.75 per share in cash.
